The document provides an analysis of the global point of care testing (POCT) market, forecasting it to reach approximately $25 billion by 2016, driven by the growing demand for accessible healthcare services. It highlights the blood glucose testing segment's dominance, accounting for 70% of the market in 2011, while predicting significant growth in infectious disease testing. The report includes detailed market dynamics, regulatory trends, competitive landscape, and emerging opportunities within the POCT sector.